Artículos

Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?

Mallo M, Salido M, Espinet B, Cervera J, Canellas A, Pajuelo JC, Pedro C, Florensa L, Sanz MA, Sole F

Bleeding and thrombosis in acute leukemia: What does the future of therapy look like?

Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T

Characteristics and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation

Puig N, de la Rubia J, Jarque I, Salavert M, Moscardó F, Sanz J, Lorenzo I, Montesinos P, Martín G, Martínez JA, Sanz GF, Blanes M, Sanz MA

Utilidad de las fluoroquinolonas en la profilaxis y el tratamiento de las infecciones del paciente hematológico

Jarque I, Sanz MA

doi: 10.1111/j.1365-2141.2007.06759.x

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes

Peggs, Karl S.; Sureda, Anna; Qian, Wendi; Caballero, Dolores; Hunter, Ann; Urbano-Ispizua, Alvaro; Cavet, James; Ribera, Josep M.; Parker, Anne; Canales, Miguel; Mahendra, Premini; Garcia-Conde, Javier; Milligan, Donald; Sanz, Guillermo; Thomson, Kirsty; Arranz, Reyes; Goldstone, Anthony H.; Alvarez, Ivan; Linch, David C.; Sierra, Jorge; Mackinnon, Stephen

doi: 10.1016/j.bbmt.2006.06.010

Encouraging Results with Inolimomab (Anti-IL-2 Receptor) as Treatment for Refractory Acute Graft-versus-Host Disease

Piñana JL, Valcárcel D, Martino R, Moreno ME, Sureda A, Briones J, Brunet S, Sierra J

doi: 10.1016/j.cancergencyto.2006.05.011

High-level amplification of the RUNX1 gene in two cases of childhood acute lymphoblasticleukemia

García-Casado Z1, Cervera J, Verdeguer A, Tasso M, Valencia A, Pajuelo JC, Mena-Duran AV, Barragán E, Blanes M, Bolufer P, Sanz MA.

doi: 10.1157/13094277

Changing epidemiological aspects of candidemia and their clinical and therapeutic implications | [Los aspectos epidemiológicos cambiantes de la candidemia y sus implicaciones clinicoterapéuticas]

Salavert Lletí M, Jarque Ramos I, Pemán García J

doi: 10.1016/j.cancergencyto.2006.02.021

New translocations in a case of atypical B-cell chronic lymphocytic leukemia: involvement of ATM,MLL, and TP53 genes

Collado R, Hueso J, Cabello AI, Oliver I, Egea M, Orero M, Miguel-Sosa A, Cigudosa JC, Benítez J, Barragán E, Carbonell F.

doi: 10.1016/j.cca.2005.12.041

A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocyticleukemia

García-Casado Z, Cervera J, Valencia A, Pajuelo JC, Mena-Duran AV, Barragán E, Bolufer P, Sanz M

doi: 10.1016/j.cca.2005.12.041

Molecular detection of Spanish deltabeta-thalassemia associated with beta-thalassemia identified during prenatal diagnosis

Barragan E1, Bolufer P, Perez ML, Prieto F, Sanz MA.

doi: 10.2147/tcrm.2006.2.2.129

Voriconazole in the management of nosocomial invasive fungal infections

Pemán J, Salavert M, Cantón E, Jarque I, Romá E, Zaragoza R, Viudes A, Gobernado M

doi: 10.1111/j.1365-2257.2006.00778.x

Automated separation of cord blood units in top and bottom bags using the Compomat G4

Solves P, Mirabet V, Carbonell-Uberos F, Soler MA, Roig R

doi: 10.1128/JCM.44.5.1912-1914.2006

Spondylodiscitis caused by Candida krusei: Case report and susceptibility patterns

Pemán J, Jarque I, Bosch M, Cantón E, Salavert M, de Llanos R, Molina A

doi: 16688286

Effect of new antifungal on the etiology of invasive fungal infections: Emergence, resistance andbreakthrough infection | [Efecto de los nuevos antifúngicos en la etiología de las micosis invasoras:Emergencia, resistencia e infección de brecha]

Salavert M, Jarque I

doi: 10.1038/sj.cdd.4401776

Loss of apoptosis-inducing factor leads to an increase in reactive oxygen species, and an impairment of respiration that can be reversed by antioxidants

Apostolova N, Cervera AM, Victor VM, Cadenas S, Sanjuan-Pla A, Alvarez-Barrientos A, Esplugues JV, McCreath KJ

doi: 10.1157/13083566

Significado pronóstico de los subtipos inmunológicos de la leucemia aguda linfoblástica T del adulto. Estudio de 81 pacientes

Xicoy B, Ribera JM, Oriol A, Sanz MA, Abella E, Tormo M, del Potro E, Bueno J, Grande C, Fernández-Calvo J, Orts M, Novo A, Rivas C, Hernández-Rivas JM, Feliu E, Ortega JJ

Epidemiology of invasive fungal infections due to Aspergillus spp. And Zygomycete (Mucus), en la web aparece con Mucus, sin Zygomycete, y con u autor más. No sé si es el mismo artículo u otro.

Sanz Alonso, M.A. Jarque Ramos, I. Salavert Lletí, M. Pemán, J.

Development of a predictive model for tumour lysis syndrome in patients with acute myeloid

Montesinos, P.

doi: 10.1111/j.1469-0691.2006.01602.x

Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes

Sanz Alonso, M.A. Jarque Ramos, I. Salavert Lletí, M. Pemán, J.

doi: 10.1159/000088340

Mode of Collection Does Not Influence Haematopoietic Content of Umbilical Cord Blood Units from Caesarean Deliveries

Solves P, Fillol M, López M, Perales A, Bonilla-Musoles F, Mirabet V, Soler MA, Roig RJ

Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

de Botton S,1 Sanz MA,* Chevret S, Dombret H, Martin G, Thomas X, Mediavilla JD, Recher C, Ades L, Quesnel B, Brault P, Fey M, Wandt H, Machover D, Guerci A, Maloisel F, Stoppa AM, Rayon C, Ribera JM, Chomienne C, Degos L, Fenaux P

Long-term survival data from a phase 3 study of filgrastim as an adjunct to chemotherapy in adults with de novo acute myeloid leukemia

Heil G, Hoelzer D, Sanz MA, Lechner K, Liu Yin J, Noens L, Szer J, Ganser A, Matcham J, Renwick J

Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)

Kelaidi C, Ades L, Chevret S, Sanz M, Guerci A, Thomas X, de Botton S, Raffoux E, Rayon C, Fegueux N, Bordessoule D, Rigal-Huguet F, Link H, Stoppa A, Vekhoff A, Meyer-Monard S, Castaigne S, Dombret H, Degos L, Fenaux P

Arsenic trioxide. Its use in the treatment of acute promyelocytic leukemia

Sanz MA, Lo-Coco F

Evaluación individualizada del riesgo de infecciones en el paciente oncohematológico

Díaz-Pedroche C, Salavert M, Aguado JM, Jarque I, Lizasoain M, Sanz MA

Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation

Puig N, de la Rubia J, Remigia MJ, Jarque I, Martín G, Cupelli L, Sanz GF, Lorenzo I, Sanz J, Martínez JA, Jiménez C, Sanz MA

Prospective study of amphotericin B formulations in immunocompromised patients in four European countries

Ullmann AJ, Sanz MA, Tramarin A, Barnes RA, Wu W, Gerlach BA, Krobot KJ, Gerth WC

Epidemiology of invasive fungal infections by Aspergillus and Mucor

Sanz MA, Jarque I, Salavert M

Recent advances in the treatment of acute promyelocytic leukemia

Sanz MA

Treatment of acute promyelocytic leukemia

Sanz MA

Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression

Bolufer P, Barragán E, Collado M, Cervera C, López JA, Sanz MA

Manejo del diagnóstico y de la fase de inducción a la remisión en pacientes con leucemia promielocític aguda

Sanz MA

Antimicrobial therapy and prevention in febrile neutropenia

Sanz MA, Jarque I, Salavert M

doi: 10.1182/blood-2005-10-4149

Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

Cheson, Bruce D.; Greenberg, Peter L.; Bennett, John M.; Lowenberg, Bob; Wijermans, Pierre W.; Nimer, Stephen D.; Pinto, Antonio; Beran, Miloslav; de Witte, Theo M.; Stone, Richard M.; Mittelman, Moshe; Sanz, Guillermo F.; Gore, Steven D.; Schiffer, Charles A.; Kantarjian, Hagop

doi: 10.1038/sj.bmt.1705195

Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia

Carreras, E; Jimenez, M; Gomez-Garcia, V; de la Camara, R; Martin, C; Martinez, F; Iriondo, A; Sanz, G; Canizo, C; Cabrera, R; Sierra, J; Vallejo, C; Lopez, J; Martinez, C; Rovira, M; Fernandez-Ranada, JM; Torres, A

doi: 10.1016/j.bbmt.2005.09.009

Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed Hodgkin lymphoma: Results of a Spanish prospective cooperative protocol

Alvarez, I; Sureda, A; Caballero, MD; Urbano-Ispizzua, A; Ribera, JM; Canales, M; Garcia-Conde, J; Sanz, G; Arranz, R; Bernal, MT; de la Serna, J; Diez, JL; Moraleda, JM; Rubio-Felix, D; Xicoy, B; Martinez, C; Mateos, MV; Sierra, J

doi: 10.1016/j.bbmt.2006.03.007

Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: Comparison of cord blood transplantation with peripheral blood and bone marrow transplantation

Parody, Rocio; Martino, Rodrigo; Rovira, Montserrat; Vazquez, Lourdes; Vazquez, Maria Jose; de la Camara, Rafael; Blazquez, Cristina; Fernandez-Aviles, Francesc; Carreras, Enric; Salavert, Miguel; Jarque, Isidro; Martin, Carmen; Martinez, Francisco; Lopez, Javier; Torres, Antonio; Sierra, Jorge; Sanz, Guilllermo F.

doi: 10.1038/sj.leu.2404215

The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow

Ingram, W.; Lea, N. C.; Cervera, J.; Germing, U.; Fenaux, P.; Cassinat, B.; Kiladjian, J. J.; Varkonyi, J.; Antunovic, P.; Westwood, N. B.; Arno, M. J.; Mohamedali, A.; Gaken, J.; Kontou, T.; Czepulkowski, B. H.; Twine, N. A.; Tamaska, J.; Csomer, J.; Benedek, S.; Gattermann, N.; Zipperer, E.; Giagounidis, A.; Garcia-Casado, Z.; Sanz, G.; Mufti, G. J.

doi: 10.1038/sj.leu.2404373

The JAK2 V617F mutation is rare in RARS but common in RARS-T

Ceesay, M. M.; Lea, N. C.; Ingram, W.; Westwood, N. B.; Gaken, J.; Mohamedali, A.; Cervera, J.; Germing, U.; Gallermann, N.; Giagounidis, A.; Garcia-Casado, Z.; Sanz, G.; Mufti, G. J.

doi: https://www.ncbi.nlm.nih.gov/pubmed/16461307

Unrelated cord blood transplants in adults with hematologic malignancies

Arcese, W; Rocha, V; Labopin, M; Sanz, G; Lori, AP; de Lima, M; Sirvent, A; Busca, A; Asano, S; Ionescu, I; Wernet, P; Gluckman, E

doi: 10.1111/j.1537-2995.2005.00612.x

Newborns’ sex and hematopoietic progenitor cell content of cord blood

Solves P, Mirabet V, Perales A, Soler MA

doi: 10.1111/j.1537-2995.2005.04357.x

Red blood cell depletion with a semiautomated system or hydroxyethyl starch sedimentation for routine cord blood banking: A comparative study

Solves P, Mirabet V, Planelles D, Blasco I, Perales A, Carbonell-Uberos F, Soler MA, Roig R

doi: 10.1016/j.febslet.2005.03.088

A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1??

Sanjuán-Pla A, Cervera AM, Apostolova N, Garcia-Bou R, Víctor VM, Murphy MP, McCreath KJ

doi: 10.1016/j.canlet.2005.03.004

An alternatively spliced transcript of the PHD3 gene retains prolyl hydroxylase activity

Cervera AM, Apostolova N, Luna-Crespo F, Sanjuan-Pla A, Garcia-Bou R, McCreath KJ

doi: 10.1093/annonc/mdi119

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin’s lymphoma autografted after a first relapse

Sureda A, Constans M, Iriondo A, Arranz R, Caballero MD, Vidal MJ, Petit J, López A, Lahuerta JJ, Carreras E, García-Conde J, García-Laraña J, Cabrera R, Jarque I, Carrera D, García-Ruiz JC, Pascual MJ, Rifón J, Moraleda JM, Pérez-Equiza K, Albó C, Díaz-Mediavilla J, Torres A, Torres P, Besalduch J, Marín J, Mateos MV, Fernández-Rañada JM, Sierra J, Conde E

doi: 10.1157/13070435

BRCA1 and BRCA2 mutations in patients with familial breast cancer | [Mutaciones en BRCA1 yBRCA2 en pacientes con historia familiar de cáncer de mama]

Bolufer P1, Munárriz B, Santaballa A, Velasco E, Lerma E, Barragán E.

Unrelated donor umbilical cord blood transplantation in adults with hematologic malignancies

Sanz, G.F.

doi: 10.1111/j.1537-2995.2005.00428.x

CD34+ cell content before freezing represents the hematopoietic stem cell content of thawed and washed cord blood units

Solves P, Mirabet V, Carbonell-Uberos F, Soler A

doi: 10.1159/000084677

Maternal, Neonatal and Collection Factors Influencing the Haematopoietic Content of Cord Blood Units

Solves P, Perales A, Moraga R, Saucedo E, Soler MA, Monleon J

Autologous and allogeneic atem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans retinoic acid: A retrospective analysis of the European Acute Promyelocytic Leukemia Group

de Botton S, Fawaz A, Chevret S, Dombret H, Thomas X, Sanz M, Guerci A, San Miguel J, de la Serna J, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux P

Tricks of the trade for the appropriate management of acute promyelocytic leukemia

Sanz MA, Tallman MS, Lo-Coco F

Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study

Sanz MA, Bermúdez A, Rovira M, Besalduch J, Pascual MJ, Nocea G, Sanz-Rodríguez C

Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent

Amadori S, Fenaux P, Ludwig H, O?Dwyer M, Sanz M

Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia

Sanz MA, Lo-Coco F

High antileukemic efficacy, excellent tolerance and high degree of compliance using all-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

Sanz MA, Vellenga E, de la Serna J, Martín G

Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence

Sanz MA, Fenaux P, Lo-Coco F

doi: 10.1157/13078098

Prevalencia y significado pronóstico de los marcadores mieloides en adultos con leucemia linfobástica de alto riesgo

Plensa E, Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández JM, Moreno MJ, del Potro E, Tormo M, Rivas C, Besalduch J, Sanz MA, Arias J, Fernández J, Moraleda JM, Bueno J, Feliu E, Ortega JJ

Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: Results from a single institution

De la Rubia J,Cantero S, Sanz GF, Remigia MJ, Monteagudo E, Moscardó F, Martín G, Lorenzo I, Jiménez C, Martínez J, Montesinos P, Jarque I, Sanz MA

SHP1 expression in bone marrow biopsies of myelodysplastic syndrome patients: a new prognostic factor

Mena-Durán A, Togo SH, Bazhenova L, Cervera J, Bethel K, Senent ML, Nieva J, Sanz GF, Sanz MA, Saven A, Mustelin T

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Ades L, Chevret S, De Botton S, Thomas X, Dombret H, Beve B, Sanz M, Guerci A, San Miguel J, de la Serna J, Garo C, Stoppa AM, Reman O, Stamatoulas A, Fey M, Cahn JY, Sotto JJ, Bourhis JH, Parry A, Chomienne C, Degos L, Fenaux F

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E, de Botton S, Thomas X, Guerci A, Fegueux N, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Ferrand A, Sanz M, Chomienne C, Fenaux P, Dombret H

Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the PETHEMA group

Ortega JJ, Madero L, Martín L, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial

Ribera JM, Oriol A, Bethencourt C, Parody R, Hernández-Rivas JM, Moreno MJ, del Potro E, Tormo M, Rivas C, Besalduch J, Sanz MA, Arias J, Fernández-Calvo J, Moraleda JM, Bueno J, Feliu E, Ortega JJ

Practice points, consensus, and controversial issues in the management of patients with newly diagnosed acute promyelocytic leukemia

Sanz MA, Tallman MS, Lo-Coco F

Manejo del paciente neutropénico con fiebre

Jarque I, Salavert M, Sanz MA

Lack of association of CYP3A4-V polymorphism with the risk of treatment-related leukemia

Collado M, Barragan E, Bolufer P, Calasanz MJ, Larrayoz MJ, Colomer D, Munarriz B, Verdeguer A, Gutierrez A, Batlle M, Sanz MA

Tratamiento empírico antifúngico en el paciente con neutropenia febril persistente: papel de la caspofungina

Sanz MA, Jarque I, Salavert M

doi: 10.1158/1078-0432.CCR-05-0941

Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-)

Caballero, D; Garcia-Macro, JA; Martino, R; Mateos, V; Ribera, JM; Sarra, J; Leon, A; Sanz, G; la Serna, JC; Cabrera, R; Gonzalez, M; Sierra, J; San Miguel, J

doi: https://www.ncbi.nlm.nih.gov/pubmed/16154839

Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes

Sole, F; Luno, E; Sanzo, C; Espinet, B; Sanz, GF; Cervera, J; Calasanz, MJ; Cigudosa, JC; Milla, F; Ribera, JM; Bureo, E; Martin, ML; Arranz, E; Florensa, L

doi: 10.1111/j.1365-2257.2004.00647.x

Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking

Solves P, Planelles D, Mirabet V, Blasco I, Carbonell-Uberos F, Soler MA, Roig RJ

doi: 10.1093/annonc/mdh391

Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin’s lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience

Rodriguez J, Caballero MD, Gutierrez A, Solano C, Arranz R, Lahuerta JJ, Sierra J, Gandarillas M, Perez-Simon JA, Zuazu J, Lopez-Guillermo A, Sureda A, Carreras E, Garcia-Laraña J, Marin J, Garcia JC, Fernandez De Sevilla A, Rifon J, Varela R, Jarque I, Albo C, Leon A, SanMiguel J, Conde E

doi: 10.1016/s0210-4806(04)73078-8

Prognostic value of DNA ploidy and nuclear morphometry in metastatic prostate cancer | [Valor pronóstico de la ploidía del ADN y la morfometría nuclear en el cáncer de próstata matastático]

Martínez Jabaloyas JM, Jiménez Sánchez A, Ruiz Cerdá JL, Sanz Chinesta S, Sempere A, Jiménez Cruz JF

doi: 10.1086/380643

Blastoschizomyces capitatus Infection in Patients with Leukemia: Report of 26 Cases

Martino R, Salavert M, Parody R, Tomás JF, de la Cámara R, Vázquez L, Jarque I, Prieto E, Sastre JL, Gadea I, Pemán J, Sierra J

doi: 10.1002/lt.20066

Genetic variability of hepatitis C virus NS3 protein in human leukocyte antigen-A2 liver transplant recipients with recurrent hepatitis C

López-Labrador FX, Berenguer M, Sempere A, Prieto M, Sirera R, González-Molina A, Ortiz V, Marty ML, Berenguer J, Gobernado M

doi: 10.1046/j.0902-4441.2003.00187.x

Optimizing donor selection in a cord blood bank

Solves P, Perales A, Mirabet V, Blasco I, Blanquer A, Planelles D, Larrea L, Monleon J, Carbonell-Uberos F, Angeles Soler M

doi: ISSN-e 0214-3429

Azoles: Prophylactics or therapeutics | [Azoles: ¿profilácticos o terapéuticos?]

Jarque, I.

doi: 10.1080/1042819031000146992

Unrelated-donor cord blood transplantion for adult hematological malignancies

Moscardó, F., Sanz, G.F., Sanz, M.A.

doi: 10.1634/stemcells.22-5-725

Selective Generation of Different Dendritic Cell Precursors from CD34+ Cells by Interleukin‐6 and Interleukin‐3

Encabo A, Solves P, Mateu E, Sepúlveda P, Carbonell-Uberos F, Miñana MD

Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA Group

Sanz MA, Martín G, González M, León A, Rayón C, Rivas C, Colomer D, Amutio E, Capote FJ, Milone GA, de la Serna J, Román J, Barragán E, Bergua J, Escoda L, Parody R, Negri S, Calasanz MJ, Bolufer P

Outcome of childhood acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy

De Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, De la Serna J, Philippe N, Baruchel A, Leverger G, Robert A, San Miguel J, Conde E, Sotto JJ, Bordessoule D, Fegueux N, Fey M, Parry A, Chomienne C, Degos L, Fenaux P

Quantitative assessment of PML-RARa and BCR-ABL by two real-time PCR instruments: Multiinstitutional laboratory trial

Bolufer P,Colomer D, Gomez MT, Martínez J, Gonzalez SM, Gonzalez M, Nomdedeu J, Bellosillo B, Barraga E, Lo Coco F, Diverio D, Hermosin L, García-Marco J, de Juan MD, Barros F, Romero R, Sanz MA

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

Sanz MA, Vellenga E, Rayón C, Díaz-Mediavilla J, Rivas C, Amutio E, Arias J, Debén G, Novo A, Bergua J, de la Serna J, Bueno J, Negri S, Beltrán de Heredia JM, Martín G

Peripheral blood stem collection after intermediate dose cytarabine improves the outcome of adult patients with acute myeloblastic leukemia undergoing autologous blood stem cell transplantation in first complete remission

De la Rubia J, Martín G, Martínez J, Lorenzo I, Sanz G, Jarque I, Moscardó F, Jiménez C, Lorente P, Camps A, Sanz MA

Immunofluorescent analysis with the anti-PML monoclonal antibody (PG-M3) for the rapid and accurate genetic diagnosis of acute promyelocytic leukemia

Gomis F, Sanz J, Sempere A, Plumé G, Senent ML, Pérez ML, Cervera J, Moscardó F, Bolufer P, Barragán E, Martín G, Sanz MA

Prognostic implications of Wilm’s tumor gene (WT1) expression in patients with the novo acute myeloid leukemia

Barragán E, Cervera J, Bolufer P, Ballester S, Martín G, Fernández P, Collado R, Sayas MJ, Sanz MA

Cord blood transplantation in patients with leukemia? A real alternative for adults

Sanz MA

Guía del Hospital Universitario La Fe para la profilaxis y el tratamiento de las infecciones fúngicas en los enfermos inmunodeprimidos o que requieren cuidados especiales

Jarque I, Salavert M, Romá E, Gobernado M, Chiveli MA, Ruano M, Solé A, Poveda JL, Ferrer E, García Pellicer J, Sanz MA, Pemán J, Sánchez V

Locked nucleic acid-enhanced detection of 1100delC*CHEK2 germ-line mutation in Spanish patients with hematologic malignancies

Collado M, Landt O, Barragán E, Lass U, Cervera J, Sanz MA, Bolufer P

Basal CD34+ cell count predicts peripheral blood progenitor cell mobilization and collection in healthy donors after administration of granulocyte colony-stimulating factor

De la Rubia J, Lorenzo JI, Torrabadella M, Marín P, Insunza A, Sanz MA

doi: 10.1158/1078-0432.CCR-04-0598

CD34(+) cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes

Suarez, L; Vidriales, MB; Garcia-Larana, J; Sanz, G; Moreno, MJ; Lopez, A; Barrena, S; Martinez, R; Tormo, M; Palomera, L; Lavilla, E; Lopez-Berges, MC; de Santiago, M; de Equiza, MEP; San Miguel, JF; Orfao, A

doi: 10.1038/sj.leu.2403386

Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34(-) bone marrow cell compartments from patients with myelodysplastic syndromes

Suarez, L; Vidriales, MB; Sanz, G; Lopez, A; Lopez-Berges, MC; de Santiago, M; Palomera, L; Bernal, T; de Equiza, MEP; San Miguel, JF; Orfao, A

doi: 10.1016/j.exphem.2004.01.002

Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

Gluckman, E; Rocha, V; Arcese, W; Michel, G; Sanz, G; Chan, KW; Takahashi, TA; Ortega, J; Filipovich, A; Locatelli, F; Asano, S; Fagioli, F; Vowels, M; Sirvent, A; Laporte, JP; Tiedemann, K; Amadori, S; Abecassis, M; Bordigoni, P; Diez, B; Shaw, PJ; Vora, A; Caniglia, M; Garnier, F; Ionescu, I; Garcia, J; Koegler, G; Rebulla, P; Chevret, S

doi: 10.1097/01.TP.0000122225.10296.10

HLA-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease

Gallardo, D; Brunet, S; Torres, A; Alonso-Nieto, M; Vallejo, C; Jimenez, A; Gonzalez, M; Sanz, G; Serrano, D; Espigado, I; Osorio, S; Carreras, E; Martin, C; Sanz-Rodriguez, C; Sierra, J; Zuazu, J; Gonzalez-Escribano, MF; Gonzalez, JR; Roman, J; de Oteyza, JP; de la Camara, R

doi: 10.1038/sj.leu.2403344

Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation

Gallardo, D; De la Camara, R; Torres, A; Brunet, S; Jimenez, A; Vallejo, JC; Sanz, G; Serrano, D; Carreras, E; Martin, C; Sanz-Rodriguez, C; Sierra, J; Espigado, I; Caballero, D; Berlanga, JJ

doi: 10.1056/NEJMoa041469

Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia

Rocha, V; Labopin, M; Sanz, G; Arcese, W; Schwerdtfeger, R; Bosi, A; Jacobsen, N; Ruutu, T; de Lima, M; Finke, J; Frassoni, F; Gluckman, E

doi: 10.1097/01.moh.0000145933.36985.eb

Umbilical cord blood transplantation

Rocha, V; Sanz, G; Gluckman, E

doi: 10.1046/j.1537-2995.2003.00459.x

In utero or ex utero cord blood collection: an unresolved question

Solves P, Moraga R, Mirabet V, Larrea L, Soler MA

doi: 10.1093/annonc/mdg206

Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcome

Constans M, Sureda A, Terol MJ, Arranz R, Caballero MD, Iriondo A, Jarque I, Carreras E, Moraleda JM, Carrera D, León A, López A, Albó C, Díaz-Mediavilla J, Fernández-Abellán P, García-Ruiz JC, Hernández-Navarro F, Mataix R, Petit J, Pascual MJ, Rifón J, García-Conde J, Fernández-Rañada JM, Mateos MV, Sierra J, Conde E

doi: 10.1034/j.1600-0412.2003.00129.x

Comparison between two cord blood collection strategies

Solves P, Mirabet V, Larrea L, Moraga R, Planelles D, Saucedo E, Uberos FC, Planells T, Guillen M, Andres A, Monleon J, Soler MA, Franco E

doi: 10.1038/sj.bmt.1703809

Comparison between two cord blood collection strategies

Solves P, Moraga R, Saucedo E, Perales A, Soler MA, Larrea L, Mirabet V, Planelles D, Carbonell-Uberos F, Monleón J, Planells T, Guillén M, Andrés A, Franco E

Umbilical cord blood transplantation: Current status and future directions

Sanz, G.F., Rocha, V.

Incidence and prognostic value of Flt3 internal tandem duplication and D835 mutations in acute myeloid leukemia

Moreno I, Martín G, Bolufer P, Barragán E, Rueda E, Román J, Fernández P, León P, Mena A, Cervera J, Torres A, Sanz MA

Factors influencing collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

Carral A, de la Rubia J, Martín G, Mollá S, Martínez J, Sanz G, Soler MA, Jarque I, Jiménez C, Sanz MA

Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia with low white blood cell counts: results from APL 93 trial

De Botton S, Chevret S, Sanz M, San Miguel J, Caillot D, Vekhof A, Dombret H, Gardin C, Cony Makhoul P, Reman O, Coiteux V, Gardembas M, Stamatoullas A, Conde E, Guerci A, De la Serna J, Lefrere F, Chomienne C, Degos L, Fenaux P, Fey M

Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemia

Sanz MA

Therapy related acute promyelocytic leukemia

Beaumont M, Sanz M, Carli PM, Maloisel F, Thomas X, Detourmignies L, Guerci A, Gratecos N, Rayon C, San Miguel J, Odriozola J, Cahn JY, Huguet F, Vekhof A, Stamatoulas A, Dombret H, Capote F, Esteve J, Stoppa AM, Fenaux P

Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study

Oriol A, Ribera JM, Esteve J, Sanz MA, Brunet S, Garcia-Boyero R, Fernández-Abellán P, Martí JM, Abella E, Sánchez-Delgado M, Peñarrubia MJ, Besalduch J, Moreno MJ, Borrego D, Feliu E, Ortega JJ

Tratamiento de las infecciones fúngicas invasivas en pacientes oncohematológicos

JarqueI, Salavert M, Sanz MA

Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation

Moscardó F, Urbano-Ispizua A, Sanz GF, Brunet S, Caballero D, Vallejo C, Solano C, Pimentel P, Pérez de Oteyza J, Ferrá C, Díez JL, Zuazu J, Espigado I, Campilho F, García-Conde J, Moraleda JM, Sierra J, Talarn C, Sanz MA

Post-transplant Burkitt’s leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial)

Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E

Choice of chemotherapy in induction, consolidation and maintenance in acute promyelocytic leukemia

Sanz MA, Martín G, Lo Coco F

de novo erythroleukemia chromosome features include multiple rearrangements with special involvement of chromosomes 11 and 19

Cigudosa JC, Odero MD, Calasanz MJ, Solé F, Salido M, Arranz E, Martínez-Ramirez A, Urioste M, Alvarez S, Cervera JV, MacGrogan D, Sanz MA, Nimer SD, Benitez J

Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation

Díaz MA, Sevilla J, de la Rubia J, Verdeguer A, Espigado A, Vicent MG, Pascual MJ, Zamora C, Arrieta R, Serrano D, Cañizo C, Arbona C, Arriba F, Bargay J, Brunet S, Sanz MA

Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience

Lobe I, Rigal-Huguet F, Vekhoff A, Desablens B, Bordessoule D, Mounier C, Ferrant A, Sanz M, Fey M, Chomienne C, Chevret S, Degos L, Fenaux P

Rasburicase (Recombinant Urate Oxidase) for the management of hyperuricemia in patients with cancer- Report of an international compassionate use study

Bosly A, Sonnet A, Pinkerton CR, McCowage G, Bron D, Sanz MA, Van den Berg H

Tratamiento de las infecciones relacionadas con catéteres venosos de larga duración

Azanza JR, Bouza E, Mensa J, Martínez JA, Picazo J, Aguado JM, Vallejo C, Sanz MA, Rovira M, Paz-Ares M, Barberán J

Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia

Sureda A, Carrasco M, de Miguel M, Martinez JA, Conde E, Sanz MA, Diaz-Mediavilla J, Sierra J

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia ? a randomized, placebo-controlled, double blind, safety

Geissler K, Liu Yin JA, Ganser A, Sanz MA, Szer J, Raghavachar A, Hoelzer D, Martinez C, Taylor K, Kanz L, To LB, Archimbaud E

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Cheson BD, Bennett JM, Kopecky K, Buchner T, Willman C, Estey E, Schiffer CA, Dohner H, Tallman M, Lister TA, LoCocco F, Willemze R, Biondi A, Hiddemann W, Larson RA, Lowenberg B, Sanz MA, Head DR, Ohno R, Bloomfield CD,

Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients

Jarque I, Andreu R, Salavert M, Gómez D, Pemán J, Gobernado M, Sanz MA

doi: 10.1038/sj.bmt.1704246

Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry

del Canizo, MC; Martinez, C; Conde, E; Vallejo, C; Brunet, S; Sanz, G; Mateos, MV

doi: PMDI: 11801462

Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblasticleukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes

Bolufer P1, Barragán E, Verdeguer A, Cervera J, Fernández JM, Moreno I, Lerma E, Esquembre C, Tasso M, Fuster V, Bermúdez M, Sanz MA.

Clinical case: Inmune thrombocytopenia as initial manifestation of mediastinal Hodgkin’s lymphoma | [Casoclínico: Trombocitopenia inmune como manifestación inicial de linfoma de Hodgkin mediastínico]

Jarque, I. Sanz, MA

Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission

Cid A, Jarque I, Salavert M, Martín G, Pérez-Bellés C, Sanz MA

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation

Arranz R, Conde E, Rodriguez ?Salvanés F, Pajuelo FJ, Cabrera R, Sanz MA, Petit J, Bueno J, Maldonado J, Odriozola J, Conde JG, Brunet S, Carreras E, Iriondo A, Fernández?Rañada JM, Marín P

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial

Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, Del Potro E, González ME, Moreno MJ, Besalduch J, Fernández J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF

FLAG-Ida regimen (fludarabine, cytarabine, g-csf and idarubicin) in the treatment of patients with high-risk myeloid malignancies

De la Rubia J, Regadera AI, Martín G, Cervera J, Sanz GF, Benlloch L, García I, Andreu R, Moscardó F, Saavedra S, Mollá S, Plumé G, Jiménez C, Martínez JA, Jarque I, Sanz MA

The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA

Baxter EJ EJ, Hochhaus A, Bolufer P, Reiter A, Fernandez JM, Senent L, Cervera J, Moscardo F, Sanz MA, Cross NCP

Identification of two atypical PML-RARalpha transcripts in two patients with acute promyelocytic leukemia

Barragán E, Bolufer P, Martín G, Cervera J, Moreno I, Capote FJ, Rosique P, Sanz MA

Analysis of factors associated with a low peripheral blood progenitor cell collection in normal donors

De la Rubia J, Arbona C, De Arriba F, Del Cañizo C, Brunet S, López J, Díaz MA, Bargay J, Petit J, De la Serna J, Insunza A, Arrieta R, Pascual MJ, Serrano D, Barbolla L, Espigado I, Alegre A, Martínez D, Verdeguer A, Martínez C, Benlloch L, Sanz MA

Cefepime plus amikacin versus piperacillin/tazobactam plus amikacin for initial antibiotic therapy in hematologic patients with febrile neutropenia: results of an open, randomized, multicenter trial

Sanz MA, López J, Lahuerta JJ, Rovira M, Batlle M, Pérez C, Vázquez L, Julià A, Palau J, Gutiérrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I for the Spanish PETHEMA Group

Factors influencing hematopoietic recovery after autologous blood stem cell transplantation patients with acute myeloblastic leukemia and non-myeloid malignancies

Carral A, de la Rubia J, Martín G, Mollá S, Martínez J, Sanz G, Soler MA, Jarque I, Jiménez C, Sanz MA

Hacia la curación de la leucemia promielocítica aguda

Sanz MA, Martín G

Tratamiento de las infecciones fúngicas invasoras en pacientes oncohematológicos

Sanz MA, Salavert M, Jarque I

Platelet transfusion and thrombotic thrombocytopenic purpura

De la Rubia J, Plumé G, Arriaga F, Carpio N, Sanz MA, Marty ML

Unrelated donor umbilical cord blood transplantation in adults

Sanz MA, Sanz GF

Risk factors for acute graft-versus-host disease in patients transplanted with CD34+ blood cells from HLA-identical siblings

Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Perez-Oteiza J, Ferra C, Zuazu J, Caballero D, Bargay J, Carvalhais A, Diez JL, Espigado I, Alegre A, Rovira M, Campilho FC, Odriozola J, Sanz MA, Sierra J, Garcia- J, Montserrat E

Rapid detection of the major mediterranean beta-thalassaemia mutations by real-time PCR using fluorophore-labelled hybridization probes

Moreno I, Bolufer P, Pérez ML, Barragán E, Sanz MA

Trombocitopenia inmune como manifestación inicial de linfoma de Hodgkin mediastínico

Jarque I, Sanz MA

Indicaciones del trasplante de progenitores hematopoyéticos

Moscardó F, Sanz GF, Sanz MA

Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34+ cell yields

De la Rubia J, Arbona C, Del Cañizo C, Arrieta R, De Arriba F, Pascual MJ, Sanjuan I, Díaz MA, Brunet S, Alegre A, Insunza A, Espigado I, Zamora C, De la Serna J, Serrano D, Bargay J, Petit J, Martínez D, Verdeguer A,Ribera JM,Martínez C,Benlloc L,Sanz MA

Infectious complications in patients undergoing unrelated donor bone marrow transplantation: Experience from a single institution

Saavedra S, Jarque I, Sanz GF, Jiménez C, Moscardó F, Plumé G, Martín G, Martínez J, De la Rubia J, Acosta B, Pemán J, Pérez-Bellés C, Gobernado M, Sanz MA

Early infections in adult patients undergoing unrelated donor cord blood transplantation

Saavedra S, Sanz GF, Jarque I, Moscardó F, Jiménez C, Lorenzo I, Martín G, Martínez J, De la Rubia J, Andreu R, Mollá S, Llopis I, Fernández MJ, Salavert M, Acosta B, Gobernado M, Sanz MA

Profilaxis y tratamiento de las infecciones fúngicas en el paciente oncohematológico

Aguado JM, García-Rodríguez JA, Gobernado M, Mensa J, Picazo J, De la Cámara R, Carreras E, Sanz MA

doi: https://www.ncbi.nlm.nih.gov/pubmed/11882281

Hematopoietic stem cell transplantation in patients or from donors with hepatitis B or C virus infection: review and recommendations

Cabrera, R; de la Camara, R; Carreras, E; Mediavilla, JD; Fores, R; Espigado, I; Lopez, J; Olive, T; Martino, R; Rifon, J; Rovira, M; Sanz, G; Solano, C; Serrano, D; Tomas, F; Varela, R; Vallejo, C

doi: 10.1182/blood-2002-02-0400

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

Martino, R; Caballero, MD; Simon, JAP; Canals, C; Solano, C; Urbano-Ispizua, A; Bargay, J; Leon, A; Sarra, J; Sanz, GF; Moraleda, JM; Brunet, S; San Miguel, J; Sierra, J

doi: 10.1046/j.1365-2141.2002.03259.x

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

Martino, R; Subira, M; Rovira, M; Solano, C; Vazquez, L; Sanz, GF; Urbano-Ispizua, A; Brunet, S; De la Camara, R

doi: 10.1046/j.1365-2141.2001.03144.x

Waldenström macroglobulinaemia: Presenting features and outcome in a series with 217 cases

García-Sanz R, Montoto S, Torrequebrada A, de Coca AG, Petit J, Sureda A, Rodríguez-García JA, Massó P, Pérez-Aliaga A, Monteagudo MD, Navarro I, Moreno G, Toledo C, Alonso A, Besses C, Besalduch J, Jarque I, Salama P, Rivas JA, Navarro B, Bladé J, Miguel JF

doi: PMID: 11602433

DMSO and non DMSO clonogenic assays from thawed cord blood

Solves P, Larrea L, Soler MA, Mirabet V, Moraga R, Franco EM

doi: 10.1200/JCO.2001.19.5.1395

Autologous stem-cell transplantation for Hodgkin’s disease: Results and prognostic factors in 494 patients

Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, García-Conde J, Jarque I, Caballero MD, Ferrà C, López A, García-Laraña J, Cabrera R, Carrera D, Ruiz-Romero MD, León A, Rifón J, Díaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Altés A, López-Guillermo A, de la Serna J, Fernández-Rañada JM, Sierra J, Conde E

Unrelated Cord Blood Transplantation (UD-CBT) in adult patients with hematologic malignancies: a report from a single centre

Sanz, Guillermo and Plumé, Gema and Jimenez, C and Senent, Leonor and Cervera, J and Larrea, Luis and Martin, Giorgos and Martínez, Jesús and Jarque, Isidro and Moscardó, Federico and Andreu, Rafa and Garcia, I and Planelles, Dolores, Barragán, Eva and Solves, Pilar and Soler, MA and Regadera, A and Marty, ML and Sanz, MA

doi: 10.1046/j.1537-2995.2001.41020302.x

Relationship between gestational age and cord blood quality

Solves P, Larrea L, Soler MA, Mirabet V

The number of donor CD3+ cells is the most important factor for graft failure after allogeneic transplantation of CD34+ selected cells from peripheral blood from HLA-identical siblings

Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S, Perez-Oteiza J, Ferra C, Zuazu J, Caballero D, Carvalhais A, Diez JL, Espigado I, Martinez C, Campilho FC, Sanz MA, Sierra J, Garcia-Conde J, Montserrat E

Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?

De la Rubia J, Arriaga F, Andreu R, Sanz G, Jiménez C, Vicente A, Carpio N, Marty ML, Sanz MA

Autologous stem cell transplantation for clinically aggressive non-hodgkin’s lymphoma: The role of preparative regimens

Salar A, Sierra J, Gandarillas J, Caballero MD, Marín J, La Huerta JJ, García-Conde J, Arranz R, León A, Zuazu J, García-Laraña J, Montserrat E, Sanz MA, Grañena A, García JC, Conde E for the GEL/TAMO Spanish Cooperative Group

Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation

De la Rubia J, Saavedra S, Sanz GF, Martín G, Moscardó F, Martínez J, Jarque I, Jiménez C, Sanz MA

Diagnóstico y clasificación de los síndromes mielodisplásicos

Vallespí T, Sanz GF, Sanz MA

Tratamiento de las infecciones fúngicas invasoras

Sanz MA, Salavert M, Jarque I

Donor age related differences in peripheral blood progenitor mobilization with recombinant human granulocyte-colony stimulating factor (rhG-CSF)

De la Rubia J, Díaz MA, Verdeguer A, Cascón P, Arbona C, Arrieta R, Brunet S, Bargay J, Martínez C, Espigado I, Serrano D, Alegre A, De Arriba F, De la Serna J, Zamora C, Benlloch L, Sanz MA

Guía clínica para la evaluación y el tratamiento del paciente neutropénico con fiebre

García-Rodríguez JA, Gobernado M, Gomis M, Mensa J, Picazo J, Prieto J, Carreras E, De la Cámara R, Sanz MA

Unrelated donor cord-blood transplantation in adults with chronic myelogenous leukemia: preliminary results in nine patients from a single institution

Sanz GF, Saavedra S, Jiménez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, De la Rubia J, Barragán E, Solves P, Soler MA, Sanz MA

Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34+ positive selection

Moscardó F, Sanz GF, De la Rubia J, Jiménez C, Saavedra S, Regadera A, Andreu R, García I, Plumé G, Martínez J, Martín G, Jarque I, Sanz MA

Association between antifungal prophylaxis and bacteremia documentation in febrile neutropenic cancer patients: a study of the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

Viscoli C, Paesmans S, Sanz M, Castagnola E, Klastersky J, Martino P, Glauser M

Successful treatment of severe intra-abdominal bleeding associated to disseminated intravascular coagulation with recombinant activated factor VII

Moscardó F, Pérez F, De la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA

Variability in the levels of PML-RARA fusion transcripts detected by the laboratories participating in an external quality control program using several RT-PCR protocols

Bolufer P, Lo Coco F, Grimwade D, Barragán E, Diverio D, Cassinat B, Chomienne Ch, Gonzalez M, Colomer D, Gomez MT, Marugan I, Román J, Delgado MD, García-Marco JA, Bornstein R, Vizmanos JL, Martinez B, Jansen J, Villegas A, De Blas J, Cabello P, Sanz MA

Recent improvements in outcome for elderly patients with de novo acute myeloblastic leukemia

López A, De la Rubia J, Martín G, Martínez J, Cervera J, Jarque I, Sempere A, Plumé G, Saavedra S, Regadera A, Sanz G, Gomis F, Pérez-Sirvent ML, Senent L, Jiménez C, Sanz MA

Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RARA isoforms: a study of the PETHEMA Group

González M, Barragán E, Bolufer P, Chillón C, Colomer D, Borstein R, Calasanz MJ, Gómez-Casares MT, Villegas A, Marugán I, Román J, Martín G, Rayón C, Debén G, Tormo M, Díaz-Mediavilla J, Esteve J, González-San Miguel J, Rivas C, Pérez-Equiza K, García-Sanz R, Capote FJ, Ribera JM, Arias J, León A, Sanz MA

Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA

Hernández JM, Martín G, Gutiérrez NC, Cervera J, Ferro MT, Calasanz MJ, Martínez-Climent JA, Luño E, Tormo M, Rayón C, Díaz-Mediavilla J, González M, González San Miguel JD, Pérez-Equiza K, Rivas C, Esteve J, Álvarez MC, Odriozola J, Ribera JM, Sanz MA

Bone marrow infiltrate by atypical histiocytic cells with cytoplasmatic Birbeck granules as initial presentation of an acute monoblastic leukemia

Gomis F, Moscardó F, Mayordomo F, Senent ML, Sempere A, Pérez ML, Marty ML, Sanz MA

Quantitative detection of AML1-ETO rearrangements by real-time RT-PCR using fluorescently labeled probes

Barragán E, Bolufer P, Moreno I, Martín G, Nomdedeu J, Brunet S, Fernández P, Rivas C, Sanz MA

Standardized, unrelated donor cord blood transplantation in adults with hematological malignancies

Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E, Jiménez C, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, García I, Mollá S, Solves P, de la Rubia J, Bolufer P, Benlloch L, Soler MA, Marty ML, Sanz MA

Trasplante de sangre de cordón umbilical de donante no emparentado con tiotepa, busulfán, ciclofosfamida y globulina antitimocítica en adultos con neoplasias hematológicas

Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E, Jiménez C, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, García I, Regadera AMollá S, Solves P, de la Rubia J, Bolufer P, Benlloch L, Soler MA, Marty ML, Sanz MA

El mieloblasto en la leucemia mieloide aguda: Morfología y citoquímica

Gomis F, Pérez-Sirvent ML, Senent L, Sempere A, Martín G, Plumé G, Marty ML, Sanz MA

Classifying chronic myelomonocytic leukemia

Greenberg P, Anderson J, Estey E, Fenaux P, Hamblin T, Hellstrom-Lindberg, List A, Ohyashiki K, Sanz G, Sanz MA

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura

De la Rubia J, Arriaga F, Linares D, Larrea L, Carpio N, Marty ML, Sanz MA

Uncertain role of increased intensity chemotherapy with high dose cytarabine in acute promyelocytic leukemia

Sanz MA, Martín G, Rayón C, Debén G, Tormo M, Díaz-Mediavilla J, Esteve J, González-San Miguel JD for the Spanish PETHEMA Cooperative Group

Absence of platelet response after eradication of Helicobacter pylori infection in patients with idiopathic thrombocytopenic purpura

Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, Jiménez C, Martín G, Martínez JA, Sanz GF, Ponce J, Sanz MA

Trasplante autólogo de progenitores hematopoyéticos de sangre periférica en leucemia mieloblástica aguda

Saavedra S, De la Rubia J, Sanz MA

doi: 10.1182/blood.V98.6.1985

Response: Myelodysplastic syndromes standardized response criteria: further definition

Cheson, BD; Bennett, JM; Kantarjian, H; Schiffer, CA; Nimer, SD; Lowenberg, B; Stone, RM; Mittelman, M; Sanz, GF; Wijermans, PW; Greenberg, PL

doi: 10.1046/j.1365-2141.2001.03013.x

Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation

Gallardo, D; Arostegui, JI; Balas, A; Torres, A; Caballero, D; Carreras, E; Brunet, S; Jimenez, A; Mataix, R; Serrano, D; Vallejo, C; Sanz, G; Solano, C; Rodriguez-Luaces, M; Marin, J; Baro, J; Sanz, C; Roman, J; Gonzalez, M; Martorell, J; Sierra, J; Martin, C; de la Camara, R; Granena, A

doi: PMID:11418365

Variability in the levels of PML-RARα fusion transcripts detected by laboratories participating in an external quality control program using several reverse transcription polymerase chain reactionprotocols

Bolufer, P. Lo Coco, F. Grimwade, D. Cabello, P. Sanz, M.-A.

Clinical evaluation of platelet concentrates transfusion obtained from Buffy-coats with PAS-2 or plasma as additive solution

Larrea L, Carpio N, Arbona C, Franco E, Solves P, Hurtado C, Soler A

doi: PMID: 10942952

Programmed versus non-programmed freezing of umbilical cord blood

Pilar S, Larrea L, Soler MA, Mirabet V, Carbonell F, Franco EM

Successful engraftment in adults undergoing unrelated umbilical cord blood transplantation (UD-UCBT)following conditioning with thiotepa (TT), busulfan (BU), cyclophosphamide (CY) and antithymocytic globulin (ATC)

Sanz, G.F. Jiménez, C. Saavedra, S. Marty, M.L. Sanz, MA

doi: 10.1046/j.1365-2141.2000.02389.x

Factor IX gene sequencing by a simple and sensitive 15-hour procedure for haemophilia B diagnosis: Identification of two novel mutations

Moscardó, F., Martínez, J.A., Sanz, G.F., Jiménez, C., Cervera, J., Sanchís, J., Vera, F.J., Sanz, M.A.

Síndromes mielodisplásicos

Sanz MA, Sanz GF

Splenectomy in patients with refractory or relapsing thrombotic thrombocytopenic purpura

De la Rubia J, García I, Jarque I, Arriaga F, Gomis F, Sanz MA

Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: The Spanish experience

Carreras E, Tomás JF, Sanz GF, Iriondo A, Boqué C, López J, Cabrera R, Sureda A, Gómez-García de Soria V, Sierra J, Sanz MA, Torres A on behalf of the CML subcommittee of the GETH

Anemia perniciosa

Saavedra S, Regadera AI, Jarque I, Sanz MA

Autologous blood cell versus marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis

Reiffers J, Labopin M, Sanz MA, Korbling M, Blaise D, De la Rubia J, Gorin NC

Leucemia promielocítica aguda. Progresos diagnósticos y terapéuticos

Sanz MA, Martín G

Neutropenia e infección

Gobernado M, Sanz MA

Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFb/MYH11 rearrangement

Martín G, Barragán E, Bolufer P, Chillón C, García-Sanz R, Gómez T, Brunet S, González M, Sanz MA

Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. a characteristic localisation of chloromas in acute promyelocytic leukemia?

Sanz MA, Larrea L, Sanz GF, Martín G, Sempere A, Gomis F, Martínez JA, Regadera A, Saavedra S, Jarque I, Jiménez C, Cervera J, De la Rubia J

Definition of relapse risk and role of non-anthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, Díaz-Mediavilla J, Fioritoni G, González JD, Liso V, Esteve J, Ferrara F, Bolufer P, Bernasconi C, Gonzalez M, Rodeghiero F, Colomer D, Petti MC, Ribera JM, Mandelli F

All-trans retinoic acid and low dose chemotherapy for acute promyelocytic leukaemia

Sanz MA, Martínez JA, Barragán E, Martín G, Lo Coco F

Long-term follow-up confirms the benefit of all transretinoic acid in acute promyelocytic leukemia

Fenaux P, Chevret S, Guerci A, Fegueux N, Dombret H, Thomas X, Sanz M, Link H, Maloisel F, Gardin C, Bordessoule D, Stoppa AM, Sadoun A, Muus P, Wandt H, Mineur P, Whittaker JA, Fey M, Daniel MT, Castaigne S, Degos L for the European APL group

Tratamiento postremisión de la leucemia mieloblástica aguda. resultados internacionales recientes

Sanz MA, Martín G

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cells

Gorin NC, Labopin M, Pichard P, Sierra J, Fiere D, Rio B, Meloni G, Sanz MA, Iriondo A, Fouillard L, Frassoni F for the ALWP of the EBMT